awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q26771999-C4CDF1D4-5CB8-47B9-9C43-AF0F30D2A670
Q26771999-C4CDF1D4-5CB8-47B9-9C43-AF0F30D2A670
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26771999-C4CDF1D4-5CB8-47B9-9C43-AF0F30D2A670
Breakthrough in heart failure with preserved ejection fraction: are we there yet?
P2860
Q26771999-C4CDF1D4-5CB8-47B9-9C43-AF0F30D2A670
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26771999-C4CDF1D4-5CB8-47B9-9C43-AF0F30D2A670
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
504c3105195dd84eccfb8e31940c3ab46a344e4f
P2860
Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial.